FR2412569A1 - Steroides, leur preparation et leur utilisation therapeutique - Google Patents

Steroides, leur preparation et leur utilisation therapeutique

Info

Publication number
FR2412569A1
FR2412569A1 FR7835775A FR7835775A FR2412569A1 FR 2412569 A1 FR2412569 A1 FR 2412569A1 FR 7835775 A FR7835775 A FR 7835775A FR 7835775 A FR7835775 A FR 7835775A FR 2412569 A1 FR2412569 A1 FR 2412569A1
Authority
FR
France
Prior art keywords
group
steroids
preparation
therapeutic use
alcanoyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7835775A
Other languages
English (en)
Other versions
FR2412569B1 (fr
Inventor
Robert George Christiansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of FR2412569A1 publication Critical patent/FR2412569A1/fr
Application granted granted Critical
Publication of FR2412569B1 publication Critical patent/FR2412569B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

L'INVENTION CONCERNE DES 2A-CYANO-3-OXOSTEROIDES DE FORMULE I: (CF DESSIN DANS BOPI) OU R EST H OU CH; R EST OH OU UN GROUPEMENT ALCANOYLOXY; R EST UN ATOME D'HYDROGENE OU UN GROUPEMENT ALKYLE, ALCENYLE OU ALCYNYLE OU BIEN R ET R PRIS ENSEMBLE REPRESENTENT UN GROUPEMENT OXO OU ETHYLENEDIOXY; R EST H OU CH; OU LEURS ALCANOATES INFERIEURS DE 3-ENOL; QUE L'ON PREPARE PAR COUPURE ALCALINE DES STEROIDO- 2,3-D ISOXAZOLES CORRESPONDANTS. CES COMPOSES ONT UNE UTILITE PHARMACEUTIQUE, EN PARTICULIER COMME AGENTS D'INTERRUPTION DE LA GROSSESSE.
FR7835775A 1977-12-20 1978-12-20 Steroides, leur preparation et leur utilisation therapeutique Granted FR2412569A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/862,417 US4160027A (en) 1977-12-20 1977-12-20 Steroid cyanoketones and intermediates

Publications (2)

Publication Number Publication Date
FR2412569A1 true FR2412569A1 (fr) 1979-07-20
FR2412569B1 FR2412569B1 (fr) 1982-05-28

Family

ID=25338450

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7835775A Granted FR2412569A1 (fr) 1977-12-20 1978-12-20 Steroides, leur preparation et leur utilisation therapeutique

Country Status (27)

Country Link
US (1) US4160027A (fr)
JP (2) JPS5488253A (fr)
AR (1) AR222645A1 (fr)
AT (1) AT367070B (fr)
AU (1) AU518997B2 (fr)
BE (1) BE872886A (fr)
CA (1) CA1121340A (fr)
CH (1) CH637409A5 (fr)
DE (1) DE2855091A1 (fr)
DK (1) DK156727C (fr)
ES (1) ES476117A1 (fr)
FI (1) FI66010C (fr)
FR (1) FR2412569A1 (fr)
GB (2) GB2010278B (fr)
HK (1) HK89287A (fr)
IE (1) IE48076B1 (fr)
IL (1) IL56076A (fr)
IT (1) IT1195258B (fr)
LU (1) LU80673A1 (fr)
MX (1) MX5535E (fr)
NL (1) NL190848C (fr)
NO (1) NO151467C (fr)
NZ (1) NZ189035A (fr)
PH (2) PH14778A (fr)
PT (1) PT68926A (fr)
SE (1) SE433221B (fr)
ZA (1) ZA786746B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349474A (en) * 1981-07-27 1982-09-14 G. D. Searle & Co. 2-Cyanosteroids
JPS5995300A (ja) * 1982-11-02 1984-06-01 スタ−リング・ドラッグ・インコ−ポレ−テッド コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物
DK23984A (da) * 1983-02-11 1984-08-12 Hoffmann La Roche D-homosteroider
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
GB8404980D0 (en) * 1984-02-25 1984-03-28 Sterwin Ag Steroid compound
DE3531903A1 (de) * 1985-09-05 1987-03-12 Schering Ag Oxytocin und antigestagen zur einleitung der geburt bzw. zum therapeutischen abbruch der graviditaet
US4755595A (en) * 1985-11-01 1988-07-05 Sterling Drug Inc. Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US5795881A (en) * 1987-06-16 1998-08-18 Schering Aktiengesellschaft Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
US5215978A (en) * 1989-06-16 1993-06-01 The Upjohn Company Method of enhancing egg laying in turkeys using epostane
JPH0538929A (ja) * 1991-08-02 1993-02-19 Mitsubishi Heavy Ind Ltd 車両用空気調和装置
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
WO2007009087A2 (fr) * 2005-07-12 2007-01-18 Dmi Biosciences, Inc. Procedes et produits de traitement de maladies
BRPI1010086A2 (pt) * 2009-06-22 2018-02-06 Dmi Acquisition Corp método e produtos para tratamento de doenças
PT2554174E (pt) * 2009-06-22 2015-12-15 Ampio Pharmaceuticals Inc Método para o tratamento de doenças
SG10201705044YA (en) 2012-12-19 2017-07-28 Ampio Pharmaceuticals Inc Method for treatment of diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
FR6368M (fr) * 1963-11-29 1968-10-14
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound

Also Published As

Publication number Publication date
IT7831011A0 (it) 1978-12-19
LU80673A1 (fr) 1979-07-20
JPS62142198A (ja) 1987-06-25
MX5535E (es) 1983-09-27
NO784281L (no) 1979-06-21
GB2010278A (en) 1979-06-27
NL7812309A (nl) 1979-06-22
DK156727B (da) 1989-09-25
JPS5488253A (en) 1979-07-13
ATA888578A (de) 1981-10-15
SE7813067L (sv) 1979-06-21
US4160027A (en) 1979-07-03
GB2010278B (en) 1982-10-20
ES476117A1 (es) 1979-11-16
NL190848B (nl) 1994-04-18
IL56076A (en) 1983-06-15
GB2088878B (en) 1983-01-19
HK89287A (en) 1987-12-11
GB2088878A (en) 1982-06-16
NZ189035A (en) 1980-08-26
JPS6220998B2 (fr) 1987-05-11
AU4208978A (en) 1979-06-28
NL190848C (nl) 1994-09-16
DK569678A (da) 1979-06-21
FR2412569B1 (fr) 1982-05-28
FI783901A (fi) 1979-06-21
IT1195258B (it) 1988-10-12
DE2855091C2 (fr) 1988-12-22
CH637409A5 (fr) 1983-07-29
PH16835A (en) 1984-03-15
NO151467B (no) 1985-01-02
AU518997B2 (en) 1981-10-29
IE48076B1 (en) 1984-09-19
PT68926A (en) 1979-01-01
NO151467C (no) 1985-04-17
CA1121340A (fr) 1982-04-06
BE872886A (fr) 1979-06-20
JPS6361314B2 (fr) 1988-11-28
AR222645A1 (es) 1981-06-15
SE433221B (sv) 1984-05-14
AT367070B (de) 1982-05-25
FI66010C (fi) 1984-08-10
DK156727C (da) 1990-03-12
IL56076A0 (en) 1979-01-31
ZA786746B (en) 1979-11-28
PH14778A (en) 1981-12-09
DE2855091A1 (de) 1979-06-28
FI66010B (fi) 1984-04-30
IE782492L (en) 1979-06-20

Similar Documents

Publication Publication Date Title
FR2412569A1 (fr) Steroides, leur preparation et leur utilisation therapeutique
FR2399023A1 (fr) Dosage de peroxyde d'hydrogene
CA2085192A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides
FR2409988A1 (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
FR2448899A1 (fr) Utilisation therapeutique de l'acide 6,7-dichloro-3,4-dihydro-3-oxo-2-quinoxalinecarboxylique et de ses esters
FR2457278A1 (fr) Utilisation therapeutique de 9-aminoalkylfluorenes
FR2374903A1 (fr) Nouvelle association utilisable en medecine veterinaire
FR2403077A1 (fr) Preparation cosmetique contenant du tripalmitate de pyridoxine
FR2358382A1 (fr) Nouveaux nonapeptides, leurs procedes de preparation et compositions pharmaceutiques les contenant
FR2385413A2 (fr)
FR2374039A1 (fr) Compositions contenant un derive de l'acide salicylique et applications a titre de medicament
FR2452483A1 (fr) Derives d'alcenylphenylmaleimides, leurs dimeres lineaires et leur procede de preparation
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
FR2451191A1 (fr) Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine
FR2411843A1 (fr) Nouvelles 6-deoxyneamines eventuellement 1-n-alkylees et intermediaires necessaires a leur preparation
FR2405942A1 (fr) Procede d'obtention du 3-oxa-tricyclo (6.2.1.02,7) undecane-4-one et son utilisation a titre d'agent parfumant
FR2447375A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
FR2413089A1 (fr) Composition de traitement de l'hypertension
FR2407941A1 (fr) Nouveaux derives de cholesterol
FR2421179A1 (fr) 3-0-(b-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques
BE904879A (fr) Alkyl ou aralkyl thio-2 cycloalkene-1 carboxamides-1 et leurs sulfoxydes, leurs procedes de preparation et leur application a la synthese de tri-et tetramethylene-4,5 isothiazoline-4 ones-3.
FR2381767A1 (fr) Pyrroloquinoxalinones et diones subsituees et leur utilisation comme medicaments
FR2359120A1 (fr) Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments
BE904605A (fr) Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique.
BE897883A (fr) Acide azetidinyl sulfonique et analogues a action therapeutique

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property